Onyx Biotec (NSE:ONYX) Total Operating Expense: ₹174.7 Mil (TTM As of Mar. 2026)


NSE:ONYX Onyx Biotec Ltd NSE:ONYX
26 GF Score
Price ₹38.60
! 6 Warning Signs
View Full Analysis

What is Onyx Biotec Total Operating Expense?

Onyx Biotec NSE:ONYX +4.89% 26 Total Operating Expense is ₹174.7 Mil as of Mar. 2026. GuruFocus rates NSE:ONYX with a GF Score™ of 26/100. The stock has 6 warning signs investors should review.

Onyx Biotec's Total Operating Expense for the six months ended in Mar. 2026 was ₹83.9 Mil. Onyx Biotec's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹174.7 Mil.

Onyx Biotec Total Operating Expense Related Terms

Onyx Biotec Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Onyx Biotec's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onyx Biotec Total Operating Expense Chart

Onyx Biotec Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
140.10 154.66 114.86 155.24 174.71

Onyx Biotec Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Operating Expense Get a 7-Day Free Trial 0.00 73.77 81.47 90.78 83.93
NSE:ONYX
26GF Score
Onyx Biotec Ltd NSE:ONYX
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onyx Biotec Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹174.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹174.7 Mil mean?
Onyx Biotec (NSE:ONYX) has a Total Operating Expense of ₹174.7 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Onyx Biotec and its competitors.
Is Onyx Biotec's Total Operating Expense too high?
Onyx Biotec's current Total Operating Expense is ₹174.7 Mil. Overall, Onyx Biotec has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Onyx Biotec's Total Operating Expense compare to ISRG and BDX?
Onyx Biotec's Total Operating Expense of ₹174.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Onyx Biotec and its competitors. Onyx Biotec's current Total Operating Expense is ₹174.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Biotec stock overvalued right now?
Onyx Biotec (NSE:ONYX) has a current Total Operating Expense of ₹174.7 Mil. The current Total Operating Expense is ₹174.7 Mil. Onyx Biotec's overall GF Score™ is 26/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Onyx Biotec (NSE:ONYX), the current Total Operating Expense is ₹174.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Onyx Biotec Business Description

Address Nalagarh Road, Near Sainimajraropar, Village Bir Plassi, Solan, HP, IND, 174101
Onyx Biotec Ltd is engaged in healthcare segment and offering Sterile Pharmaceutical products ,and acts as a pharmaceutical contract manufacturer. It offering products such as Sterile Water for Injections, Dry Powder Injections and Dry Syrup for India and overseas. Key revenue is generated from Sterile Water for Injections .
26GF Score

Get the complete analysis for NSE:ONYX

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹38.60
Price